Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males

被引:319
作者
Zellweger, R
Wichmann, MW
Ayala, A
Stein, S
DeMaso, CM
Chaudry, IH
机构
[1] RHODE ISL HOSP,SURG RES CTR,PROVIDENCE,RI 02903
[2] BROWN UNIV,SCH MED,PROVIDENCE,RI 02903
[3] MICHIGAN STATE UNIV,DEPT SURG,E LANSING,MI 48824
[4] MICHIGAN STATE UNIV,DEPT MICROBIOL,E LANSING,MI 48824
[5] MICHIGAN STATE UNIV,DEPT UNIV LAB ANIM RESOURCES,E LANSING,MI 48824
[6] MICHIGAN STATE UNIV,DEPT PHYSIOL,E LANSING,MI 48824
[7] MICHIGAN STATE UNIV,SHOCK & TRAUMA RES INST,E LANSING,MI 48824
关键词
male; female; C3H/HeN mice; splenocyte proliferation; interleukin; interleukin d; sepsis; survival;
D O I
10.1097/00003246-199701000-00021
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To determine: a) whether the cell-mediated immune response during sepsis differs in females vs, males; and b) whether the survival rate in females is different than in males after a septic insult, Design: A prospective, randomized animal study, Setting: University research laboratory, Subjects: Male and female proestrus C3H/HeN mice, interventions: After anesthesia, male and proestrus female mice underwent cecal ligation puncture to induce sepsis, The mice were killed at 24 hrs after the onset of sepsis, Measurements and Main Results: Splenocyte proliferation, as well as splenocyte interleukin (IL)-2 and IL-3 release, was determined by bioassay, In additional studies, survival rate after septic challenge was measured over 10 days, Splenocyte proliferative capacity and splenocyte IL-2 and IL-3 release were markedly decreased in male, but not in female, septic mice, Furthermore, the survival rate of septic female proestrus mice was significantly higher than in comparable male mice, Conclusions: These results support the concept that the immune response of females differs from males, and that females are immunologically better positioned to meet the challenge of sepsis.
引用
收藏
页码:106 / 110
页数:5
相关论文
共 38 条
  • [1] AHMED SA, 1985, AM J PATHOL, V121, P531
  • [2] AINBENDER E, 1968, J IMMUNOL, V101, P92
  • [3] ANSAR AS, 1985, AM J PATHOL, V121, P531
  • [4] SUBSET-SPECIFIC EFFECTS OF SEX-HORMONES AND PITUITARY GONADOTROPINS ON HUMAN LYMPHOCYTE-PROLIFERATION INVITRO
    ATHREYA, BH
    PLETCHER, J
    ZULIAN, F
    WEINER, DB
    WILLIAMS, WV
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 66 (03): : 201 - 211
  • [5] AYALA A, 1993, ARCH SURG-CHICAGO, V128, P89
  • [6] BAKER CC, 1983, SURGERY, V94, P331
  • [7] BARROW RE, 1990, SURG GYNECOL OBSTET, V170, P295
  • [8] RELEASE OF MULTIPLE HORMONES BY A DIRECT ACTION OF INTERLEUKIN-1 ON PITUITARY-CELLS
    BERNTON, EW
    BEACH, JE
    HOLADAY, JW
    SMALLRIDGE, RC
    FEIN, HG
    [J]. SCIENCE, 1987, 238 (4826) : 519 - 521
  • [9] BESEDOVSKY H, 1977, CLIN EXP IMMUNOL, V27, P1
  • [10] TOWARD AN EPIDEMIOLOGY AND NATURAL-HISTORY OF SIRS (SYSTEMIC INFLAMMATORY RESPONSE SYNDROME)
    BONE, RC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (24): : 3452 - 3455